Id |
Subject |
Object |
Predicate |
Lexical cue |
T499 |
0-20 |
Sentence |
denotes |
Author Contributions |
T500 |
21-259 |
Sentence |
denotes |
Conceptualization, A.M.A.; methodology, A.M.A.; software, A.M.A.; validation, A.M.A.; writing—original draft preparation, A.M.A.; writing—review and editing, H.K.; supervision, H.K.; project administration, H.K.; funding acquisition, H.K. |
T501 |
260-336 |
Sentence |
denotes |
All authors have read and agreed to the published version of the manuscript. |
T502 |
338-345 |
Sentence |
denotes |
Funding |
T503 |
346-502 |
Sentence |
denotes |
This study was supported by the Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and development, AMED, Japan (Grant No. |
T504 |
503-521 |
Sentence |
denotes |
18dm0107100h0003). |
T505 |
523-544 |
Sentence |
denotes |
Conflicts of Interest |
T506 |
545-589 |
Sentence |
denotes |
The authors declare no conflict of interest. |
T507 |
590-603 |
Sentence |
denotes |
Abbreviations |
T508 |
604-671 |
Sentence |
denotes |
4eBP1/eIF4E Eukaryotic translation initiation 4E-binding protein 1 |
T509 |
672-712 |
Sentence |
denotes |
10-HDA trans-10-hydroxy-2-decenoic acid |
T510 |
713-750 |
Sentence |
denotes |
AGEs Advanced glycation end products |
T511 |
751-806 |
Sentence |
denotes |
AKT A serine/threonine nutrient sensing protein kinase |
T512 |
807-835 |
Sentence |
denotes |
AMP Adenosine monophosphate |
T513 |
836-890 |
Sentence |
denotes |
AMPK Adenosine monophosphate activated protein kinase |
T514 |
891-924 |
Sentence |
denotes |
ARE Antioxidant response element |
T515 |
925-964 |
Sentence |
denotes |
ATF4 Activating transcription factor-4 |
T516 |
965-993 |
Sentence |
denotes |
ATP Adenosine tri-phosphate |
T517 |
994-1013 |
Sentence |
denotes |
COX Cyclooxygenase |
T518 |
1014-1053 |
Sentence |
denotes |
eNOs Endothelial nitric oxide synthase |
T519 |
1054-1079 |
Sentence |
denotes |
ER Endoplasmic reticulum |
T520 |
1080-1100 |
Sentence |
denotes |
FOXO Forkhead box O |
T521 |
1101-1121 |
Sentence |
denotes |
GI Gastrointestinal |
T522 |
1122-1150 |
Sentence |
denotes |
GLUT4 Glucose transporter 4 |
T523 |
1151-1179 |
Sentence |
denotes |
HET Heterogeneous head tilt |
T524 |
1180-1198 |
Sentence |
denotes |
HFD High fat diet |
T525 |
1199-1228 |
Sentence |
denotes |
HIF Hypoxia-inducible factor |
T526 |
1229-1251 |
Sentence |
denotes |
HO-1 Heme oxygenase 1 |
T527 |
1252-1311 |
Sentence |
denotes |
HOMA-IR Homeostatic model assessment of insulin resistance |
T528 |
1312-1327 |
Sentence |
denotes |
IKK IκB kinase |
T529 |
1328-1361 |
Sentence |
denotes |
IGFs Insulin-like growth factors |
T530 |
1362-1377 |
Sentence |
denotes |
IL Interleukin |
T531 |
1378-1415 |
Sentence |
denotes |
iNOS Inducible nitric oxide synthase |
T532 |
1416-1436 |
Sentence |
denotes |
IR Insulin receptor |
T533 |
1437-1479 |
Sentence |
denotes |
LESM Lower extremity skeletal muscle mass |
T534 |
1480-1518 |
Sentence |
denotes |
MAPK Mitogen-activated protein kinase |
T535 |
1519-1539 |
Sentence |
denotes |
MDA Malondialdehyde |
T536 |
1540-1575 |
Sentence |
denotes |
mTOR Mammalian target of rapamycin |
T537 |
1576-1604 |
Sentence |
denotes |
MMP-12 Metalloproteinase-12 |
T538 |
1605-1642 |
Sentence |
denotes |
MCP-1 Monocyte chemotactic protein 1 |
T539 |
1643-1676 |
Sentence |
denotes |
MRJPs Major royal jelly proteins |
T540 |
1677-1709 |
Sentence |
denotes |
MyoD Myogenic differentiation 1 |
T541 |
1710-1739 |
Sentence |
denotes |
NF-kB Nuclear factor kappa-B |
T542 |
1740-1801 |
Sentence |
denotes |
NRF2 Nuclear factor erythroid 2/Nuclear respiratory factor 2 |
T543 |
1802-1878 |
Sentence |
denotes |
PGC-1α Peroxisome proliferator-activated receptor gamma coactivator 1 alpha |
T544 |
1879-1910 |
Sentence |
denotes |
PI3k Phosphoinositide-3 kinase |
T545 |
1911-1944 |
Sentence |
denotes |
PUFA Polyunsaturated fatty acids |
T546 |
1945-1966 |
Sentence |
denotes |
PKC Protein kinase C |
T547 |
1967-2000 |
Sentence |
denotes |
pRJ Protease-treated royal jelly |
T548 |
2001-2021 |
Sentence |
denotes |
QOL Quality of life |
T549 |
2022-2072 |
Sentence |
denotes |
RAGE Receptor for Advanced Glycation End products |
T550 |
2073-2102 |
Sentence |
denotes |
RCT Randomized control trial |
T551 |
2103-2131 |
Sentence |
denotes |
ROS Reactive oxygen species |
T552 |
2132-2156 |
Sentence |
denotes |
SDs Standard deviations |
T553 |
2157-2194 |
Sentence |
denotes |
S6K P70 ribosomal proteins S6 kinase |
T554 |
2195-2259 |
Sentence |
denotes |
SMART Specific of Muscle Atrophy and Regulated by Transcription |
T555 |
2260-2286 |
Sentence |
denotes |
TNF Tumor necrosis factor |
T556 |
2287-2326 |
Sentence |
denotes |
TNFR1 Tumor necrosis factor receptor 1 |
T557 |
2327-2371 |
Sentence |
denotes |
VEGF-A Vascular endothelial growth factor A |
T558 |
2372-2407 |
Sentence |
denotes |
VSMCs Vascular smooth muscle cells |